{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:45:24Z","timestamp":1790815524260,"version":"4.1.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T00:00:00Z","timestamp":1702252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1038\/s41433-023-02856-7","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T15:02:55Z","timestamp":1702306975000},"page":"1168-1172","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Dysthyroid optic neuropathy: a case series at a tertiary ophthalmic referral centre"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0671-244X","authenticated-orcid":false,"given":"In Young","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jwu Jin","family":"Khong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,11]]},"reference":[{"key":"2856_CR1","unstructured":"Agarwal A, Khanam S. Dysthyroid optic neuropathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK564299\/."},{"key":"2856_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2147\/EB.S23238","volume":"3","author":"SO Ahmed","year":"2011","unstructured":"Ahmed SO, Lee AG. Dysthyroid optic neuropathy: a review. Eye Brain. 2011;3:25\u201336. https:\/\/doi.org\/10.2147\/EB.S23238.","journal-title":"Eye Brain"},{"key":"2856_CR3","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/bjo.2006.094607","volume":"91","author":"D McKeag","year":"2007","unstructured":"McKeag D, Lane C, Lazarus JH, Baldeschi L, Boboridis K, Dickinson AJ, et al. Clinical features of dysthyroid optic neuropathy: a European Group on Graves\u2019 Orbitopathy (EUGOGO) survey. Br J Ophthalmol. 2007;91:455\u20138. https:\/\/doi.org\/10.1136\/bjo.2006.094607.","journal-title":"Br J Ophthalmol"},{"key":"2856_CR4","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/bjo.2006.110932","volume":"91","author":"CM Dayan","year":"2007","unstructured":"Dayan CM, Dayan MR. Dysthyroid optic neuropathy: a clinical diagnosis or a definable entity? Br J Ophthalmol. 2007;91:409\u201310.","journal-title":"Br J Ophthalmol"},{"key":"2856_CR5","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1883360\/v1","author":"A Andrade","year":"2022","unstructured":"Andrade A, Faria T, Meneghim R, Hashimoto M, Jorge E, Jorge E. Detection of dysthyroid optic neuropathy by optical coherence tomography. Res Sq. 2022. https:\/\/doi.org\/10.21203\/rs.3.rs-1883360\/v1.","journal-title":"Res Sq"},{"key":"2856_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41433-021-01453-w","volume":"36","author":"J Guo","year":"2022","unstructured":"Guo J, Li X, Ma R, Gan L, Qian J. The changes of retinal nerve fibre layer and ganglion cell layer with different severity of thyroid eye disease. Eye. 2022;36:129\u201334. https:\/\/doi.org\/10.1038\/s41433-021-01453-w.","journal-title":"Eye"},{"key":"2856_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211062030","author":"L Luo","year":"2021","unstructured":"Luo L, Li D, Gao L, Wang W. Retinal nerve fiber layer and ganglion cell complex thickness as a diagnostic tool in early stage dysthyroid optic neuropathy. Eur J Ophthalmol. 2021. https:\/\/doi.org\/10.1177\/11206721211062030.","journal-title":"Eur J Ophthalmol"},{"key":"2856_CR8","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1080\/01676830.2020.1846761","volume":"41","author":"TV Dave","year":"2022","unstructured":"Dave TV, Laghmisetty S, Krishnamurthy G, Bejjanki K, Ganguly A, Jonnadula GB, et al. Retinal vascularity, nerve fiber, and ganglion cell layer thickness in thyroid eye disease on optical coherence tomography angiography. Orbit. 2022;41:170\u20137.","journal-title":"Orbit."},{"key":"2856_CR9","doi-asserted-by":"publisher","unstructured":"Ferreri FM, Ferreri G. Introductory chapter: the dysthyroid optic neuropathy. In: Ferreri FM, editor. Optic Nerve. Rijeka: IntechOpen; 2018. Chapter 1. https:\/\/doi.org\/10.5772\/intechopen.82491.","DOI":"10.5772\/intechopen.82491"},{"key":"2856_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/17469899.2017.1276444","volume":"12","author":"AD Blandford","year":"2017","unstructured":"Blandford AD, Zhang D, Chundury RV, Perry JD. Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management. Expert Rev Ophthalmol. 2017;12:111\u201321. https:\/\/doi.org\/10.1080\/17469899.2017.1276444.","journal-title":"Expert Rev Ophthalmol"},{"key":"2856_CR11","doi-asserted-by":"publisher","first-page":"G43","DOI":"10.1530\/EJE-21-0479","volume":"185","author":"L Bartalena","year":"2021","unstructured":"Bartalena L, Kahaly GJ, Baldeschi L, Dayan CM, Eckstein A, Marcocci C, et al. The 2021 European Group on Graves\u2019 orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves\u2019 orbitopathy. Eur J Endocrinol. 2021;185:G43\u201367. https:\/\/doi.org\/10.1530\/EJE-21-0479.","journal-title":"Eur J Endocrinol"},{"key":"2856_CR12","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","volume":"376","author":"TJ Smith","year":"2017","unstructured":"Smith TJ, Kahaly GJ, Ezra DG, Fleming JC, Dailey RA, Tang RA, et al. Teprotumumab for thyroid-associated ophthalmopathy. N Engl J Med. 2017;376:1748\u201361.","journal-title":"N Engl J Med"},{"key":"2856_CR13","doi-asserted-by":"publisher","first-page":"1702","DOI":"10.1210\/jc.2017-02182","volume":"103","author":"L Bartalena","year":"2018","unstructured":"Bartalena L, Krassas GE, Wiersinga WM, Marcocci C, Salvi M, Daumerie C, et al. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active graves\u2019 orbitopathy. J Clin Endocrinol Metab. 2018;103:1702\u201311. https:\/\/doi.org\/10.1210\/jc.2017-02182.","journal-title":"J Clin Endocrinol Metab"},{"key":"2856_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1159\/000505343","volume":"9","author":"I Mombaerts","year":"2020","unstructured":"Mombaerts I, Schiettecatte J, Decallonne B, Velkeniers B. Successful treatment of compressive optic neuropathy with tocilizumab in a patient with thyroid-associated orbitopathy. Eur Thyroid J. 2020;9:163\u20137. https:\/\/doi.org\/10.1159\/000505343.","journal-title":"Eur Thyroid J"},{"key":"2856_CR15","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1089\/thy.2013.0445","volume":"24","author":"N Curr\u00f2","year":"2014","unstructured":"Curr\u00f2 N, Covelli D, Vannucchi G, Campi I, Pirola G, Simonetta S, et al. Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy. Thyroid. 2014;24:897\u2013905. https:\/\/doi.org\/10.1089\/thy.2013.0445.","journal-title":"Thyroid."},{"key":"2856_CR16","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/0002-9394(84)90127-2","volume":"102","author":"ME Migliori","year":"1984","unstructured":"Migliori ME, Gladstone GJ. Determination of the normal range of exophthalmometric values for black and white adults. Arch Ophthalmol. 1984;102:981\u20132. https:\/\/doi.org\/10.1016\/0002-9394(84)90127-2.","journal-title":"Arch Ophthalmol"},{"key":"2856_CR17","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/sj.eye.6701925","volume":"20","author":"CC Tsai","year":"2006","unstructured":"Tsai CC, Kau HC, Kao SC, Hsu WM. Exophthalmos of patients with Graves\u2019 disease in Chinese of Taiwan. Eye. 2006;20:569\u201373. https:\/\/doi.org\/10.1038\/sj.eye.6701925.","journal-title":"Eye"},{"key":"2856_CR18","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb01080.x","volume":"38","author":"P Perros","year":"1993","unstructured":"Perros P. The thyrotropin receptor and thyroid eye disease. Clin Endocrinol. 1993;38:367\u201372. https:\/\/doi.org\/10.1111\/j.1365-2265.1993.tb01080.x.","journal-title":"Clin Endocrinol"},{"key":"2856_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1001\/archopht.1993.01090020051024","volume":"111","author":"DL Kendler","year":"1993","unstructured":"Kendler DL, Lippa J, Rootman J. The initial clinical characteristics of Graves\u2019 orbitopathy vary with age and sex. Arch Ophthalmol. 1993;111:197\u2013201. https:\/\/doi.org\/10.1001\/archopht.1993.01090020051024.","journal-title":"Arch Ophthalmol"},{"key":"2856_CR20","doi-asserted-by":"publisher","first-page":"2711","DOI":"10.1210\/jc.2015-4294","volume":"101","author":"JJ Khong","year":"2016","unstructured":"Khong JJ, Finch S, De Silva C, Rylander S, Craig JE, Selva D, et al. Risk factors for graves\u2019 orbitopathy; the Australian thyroid-associated orbitopathy research (ATOR) study. J Clin Endocrinol Metab. 2016;101:2711\u201320. https:\/\/doi.org\/10.1210\/jc.2015-4294.","journal-title":"J Clin Endocrinol Metab"},{"key":"2856_CR21","doi-asserted-by":"publisher","first-page":"4873","DOI":"10.1210\/jc.2006-1402","volume":"91","author":"N Manji","year":"2006","unstructured":"Manji N, Carr-Smith JD, Boelaert K, Allahabadia A, Armitage M, Chatterjee VK, et al. Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab. 2006;91:4873\u201380. https:\/\/doi.org\/10.1210\/jc.2006-1402.","journal-title":"J Clin Endocrinol Metab"},{"key":"2856_CR22","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1038\/s41433-018-0144-x","volume":"32","author":"Y Wong","year":"2018","unstructured":"Wong Y, Dickinson J, Perros P, Dayan C, Veeramani P, Morris D, et al. A British Ophthalmological Surveillance Unit (BOSU) study into dysthyroid optic neuropathy in the United Kingdom. Eye. 2018;32:1555\u201362. https:\/\/doi.org\/10.1038\/s41433-018-0144-x.","journal-title":"Eye"},{"key":"2856_CR23","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0007-1226(97)91299-6","volume":"50","author":"M West","year":"1997","unstructured":"West M, Stranc M. Long-term results of four-wall orbital decompression for Graves\u2019 ophthalmopathy. Br J Plast Surg. 1997;50:507\u201316.","journal-title":"Br J Plast Surg"},{"key":"2856_CR24","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1016\/S0025-6196(12)61785-6","volume":"69","author":"V Fatourechi","year":"1994","unstructured":"Fatourechi V, Bergstralh EJ, Garrity JA, Bartley GB, Beatty CW, Offord KP, et al. Predictors of response to transantral orbital decompression in severe Graves\u2019 ophthalmopathy. Mayo Clin Proc. 1994;69:841\u20138.","journal-title":"Mayo Clin Proc"},{"key":"2856_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3109\/02713683.2015.1008641","volume":"41","author":"S Korkmaz","year":"2016","unstructured":"Korkmaz S, Konuk O. Surgical treatment of dysthyroid optic neuropathy: long-term visual outcomes with comparison of 2-wall versus 3-wall orbital decompression. Curr Eye Res. 2016;41:159\u201364.","journal-title":"Curr Eye Res"},{"key":"2856_CR26","doi-asserted-by":"publisher","first-page":"e14162","DOI":"10.1097\/MD.0000000000014162","volume":"98","author":"QW Liang","year":"2019","unstructured":"Liang QW, Yang H, Luo W, He JF, Du Y. Effect of orbital decompression on dysthyroid optic neuropathy: a retrospective case series. Medicine. 2019;98:e14162.","journal-title":"Medicine"},{"key":"2856_CR27","doi-asserted-by":"publisher","first-page":"73","DOI":"10.3341\/kjo.2012.26.2.73","volume":"26","author":"C Jeon","year":"2012","unstructured":"Jeon C, Shin JH, Woo KI, Kim YD. Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy. Korean J Ophthalmol. 2012;26:73\u20139. https:\/\/doi.org\/10.3341\/kjo.2012.26.2.73.","journal-title":"Korean J Ophthalmol"},{"key":"2856_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-020-1314-8","volume":"20","author":"M Tagami","year":"2020","unstructured":"Tagami M, Honda S, Azumi A. Preoperative clinical factors and visual outcomes following orbital decompression with dysthyroid optic neuropathy. BMC Ophthalmol. 2020;20:30 https:\/\/doi.org\/10.1186\/s12886-020-1314-8.","journal-title":"BMC Ophthalmol"},{"key":"2856_CR29","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1089\/thy.1992.2.229","volume":"2","author":"WM Wiersinga","year":"1992","unstructured":"Wiersinga WM. Immunosuppressive treatment of Graves\u2019 ophthalmopathy. Thyroid. 1992;2:229\u201333.","journal-title":"Thyroid."},{"key":"2856_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-023-02789-5","volume":"23","author":"P Kemchoknatee","year":"2023","unstructured":"Kemchoknatee P, Tangon D, Srisombut T. A single-center analysis of visual outcomes and associated factors after intravenous methylprednisolone treatment for dysthyroid optic neuropathy. BMC Ophthalmol. 2023;23:32.","journal-title":"BMC Ophthalmol"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02856-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02856-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02856-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T14:07:22Z","timestamp":1712844442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-023-02856-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2856"],"URL":"https:\/\/doi.org\/10.1038\/s41433-023-02856-7","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,11]]},"assertion":[{"value":"27 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}